Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2006 1
2007 1
2009 1
2010 2
2011 5
2012 1
2013 1
2014 2
2015 5
2016 1
2017 2
2018 5
2019 2
2020 3
2021 8
2022 13
2023 10
2024 13
2025 23
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean z abbas (1 results)?
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.
Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Abubakirov A, Baudin E, Berikova E, Berry C, Bonnet M, Cellamare M, Chavan V, Cox V, Dakenova Z, de Jong BC, Ferlazzo G, Karabayev A, Kirakosyan O, Kiria N, Kunda M, Lachenal N, Lecca L, McIlleron H, Motta I, Toscano SM, Mushtaque H, Nahid P, Oyewusi L, Panda S, Patil S, Phillips PPJ, Ruiz J, Salahuddin N, Garavito ES, Seung KJ, Ticona E, Trippa L, Vasquez DEV, Wasserman S, Rich ML, Varaine F, Mitnick CD; endTB Clinical Trial Team. Guglielmetti L, et al. N Engl J Med. 2025 Jan 30;392(5):468-482. doi: 10.1056/NEJMoa2400327. N Engl J Med. 2025. PMID: 39879593 Free PMC article. Clinical Trial.
METHODS: We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for treatment of fluoroquinolone-susceptible, rifampin-resistant tuberculosis with five 9-month oral regimens that included various combinations of …
METHODS: We conducted a phase 3, multinational, open-label, randomized, controlled noninferiority trial to compare standard therapy for trea …
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Demographics Collaborators. GBD 2021 Demographics Collaborators. Lancet. 2024 May 18;403(10440):1989-2056. doi: 10.1016/S0140-6736(24)00476-8. Epub 2024 Mar 11. Lancet. 2024. PMID: 38484753 Free PMC article.
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.
FUNDING: UK Research and Innovation (Medical Research Council) and National Institute of Health Research (MC_PC_19056), and Wellcome Trust (222406/Z/20/Z). TRANSLATIONS: For the Nepali, Hindi, Indonesian (Bahasa) and Vietnamese translations of the abstract see Suppl …
FUNDING: UK Research and Innovation (Medical Research Council) and National Institute of Health Research (MC_PC_19056), and Wellcome Trust ( …
Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome.
Koprulu M, Smith-Byrne K, Ferolito BR, Macdonald-Dunlop E, Luan J, Hedman ÅK, Ogamba CF, Kuliesius J, Repetto L, Ramisch A, Abbasi F, Ärnlöv J, Assimes TL; BeLOVE Study Group; Björck HM, Björkander S, Böttcher M, Butterworth AS, Chen Z, Cho K, Clarke RJ, Cox SR, Czene K, Danesh J, Dedoussis G, Elmståhl S, Eriksson N, Eriksson P, Esko T; Estonian Biobank Research Team; Ferreiro-Iglesias A, Franks PW, Fu J, Gaziano JM, Ghanbari M, Gieger C, Gilly A, Grallert H, Gunter MJ, Gustafsson S, Göteson A, Hall PFL, Hansson O, Harris SE, Hayward C, Herder C, Hernandez-Pacheco N, Hijazi Z, Hillary RF, Hopewell JC, Hu S, Hwang SJ, Jern C, Johansson Å, Jonsson L, Kalnapenkis A, Kerrison ND, Kho PF, Klaric L, Kohleick L, Kraft J, Landén M, Levy D, Li L, Lind L, Long J, Mattsson-Carlgren N, Melén E, Merid SK, Mertins P, Michaëlsson K, Møller PL, Murgia F, Nyegaard M, Park YC, Pearson E, Peters J, Petrie JR, Png G, Polašek O, Prins BP, Ripke S, Roden M, Rohde PD, Said S; SCALLOP Consortium; Shen X, Schwenk JM, Siegbahn A, Smith JG, Stanne TM, Suhre K, Sundström J, Thorand B, Valdes-Marquez E, Vallerga CL, van Meurs JBJ, Viñuela A, Võsa U, Wallentin L, Walters RG, Wareham NJ, Weber JE, Weersma RK, W… See abstract for full author list ➔ Koprulu M, et al. Cell. 2026 May 28;189(11):3339-3357.e11. doi: 10.1016/j.cell.2026.03.049. Epub 2026 May 6. Cell. 2026. PMID: 42097137 Free article.
Time to Full Enteral Feeds and Late-Onset Sepsis in Extremely Preterm Infants.
Salas AA, Wiener LE, Trotta M, Valcarce V, Romero-Lopez M, Ortigoza EB, Fu TT, McNelis K, Poindexter B, Carlo WA; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Salas AA, et al. JAMA Netw Open. 2025 Nov 3;8(11):e2543940. doi: 10.1001/jamanetworkopen.2025.43940. JAMA Netw Open. 2025. PMID: 41247732 Free PMC article.
Other clinical outcomes assessed up to 36 weeks of postmenstrual age included necrotizing enterocolitis, death, and growth faltering (weight, length, or head circumference z score decrease >1.2). Risk estimates were adjusted for clinical variables associated with acute …
Other clinical outcomes assessed up to 36 weeks of postmenstrual age included necrotizing enterocolitis, death, and growth faltering (weight …
90 results